Sort
16,300 grants matching “fatty liver disease”
An anti-diabetic microRNA that promotes metabolically healthy obesity
$396,250Sean Hartig · Baylor College Of Medicine · R01 · FY2021 · DK
The molecular basis of liver induced retinal blood vessel plasticity.
$396,250Jonathan E Sears · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · EY
Enzymatic Control of Trimethylamineoxide (TMAO)Induced Atherosclerosis
$396,250Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · HL
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis
$396,250Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · HL
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis
$396,250Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · HL
Apolipoprotein F enhances HDL function
$396,250Richard E Morton · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · HL
Probing Cardiovascular Actions of GLP-1 Using Nanoparticles
$396,250Andrei Maiseyeu · Case Western Reserve University · R01 · FY2019 · HL
Probing Cardiovascular Actions of GLP-1 Using Nanoparticles
$396,250Andrei Maiseyeu · Case Western Reserve University · R01 · FY2017 · HL
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease
$396,250Philip W Shaul · Ut Southwestern Medical Center · R01 · FY2011 · HL
An anti-diabetic microRNA that promotes metabolically healthy obesity
$396,250Sean Hartig · Baylor College Of Medicine · R01 · FY2019 · DK
Novel animal models to study miRNA-mediated alcoholic liver disease
$396,250Suthat Liangpunsakul · Indiana University Indianapolis · UH3 · FY2020 · AA
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease
$396,250Philip W Shaul · Ut Southwestern Medical Center · R01 · FY2010 · HL
An anti-diabetic microRNA that promotes metabolically healthy obesity
$396,250Sean Hartig · Baylor College Of Medicine · R01 · FY2020 · DK
Probing Cardiovascular Actions of GLP-1 Using Nanoparticles
$396,250Andrei Maiseyeu · Case Western Reserve University · R01 · FY2020 · HL
Metabolism of the VLDL receptor and ApoE receptor 2
$396,250Joachim J Herz · Ut Southwestern Medical Center · R37 · FY2010 · HL
The molecular basis of liver induced retinal blood vessel plasticity.
$396,250Jonathan E Sears · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · EY
Vascular and Neuronal Repair with Adipose Stromal cells in Retinopathy
$396,249Rajashekhar Gangaraju · Indiana University Indianapolis · R01 · FY2014 · EY
Predominant protective role in hepatic steatosis and obesity by fish oil-derived furans
$396,123Francisco Jose Schopfer · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · DK
Predominant protective role in hepatic steatosis and obesity by fish oil-derived furans
$396,123Francisco Jose Schopfer · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Predominant protective role in hepatic steatosis and obesity by fish oil-derived furans
$396,123Francisco Jose Schopfer · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DK
Bile acids and metabolic surgery
$396,000Wendong Huang · Beckman Research Institute/City Of Hope · R01 · FY2020 · DK
Bile acids and metabolic surgery
$396,000Wendong Huang · Beckman Research Institute/City Of Hope · R01 · FY2023 · DK
Bile acids and metabolic surgery
$396,000Wendong Huang · Beckman Research Institute/City Of Hope · R01 · FY2022 · DK
Transgenerational effects of endocrine disruptors: epigenetics and physiology
$396,000Marisa S. Bartolomei · University Of Pennsylvania · R01 · FY2014 · ES
Bile acids and metabolic surgery
$396,000Wendong Huang · Beckman Research Institute/City Of Hope · R01 · FY2021 · DK